Search

everythinglearnresearchcommunity

for

Search:↓

New small molecule drugs could help treat hair loss.

Arsenic exposure from contaminated water severely damages the skin, causing hair loss, pigmentation changes, irritation, and can lead to skin cancer.

A new mutation in the Hairless gene causes hair loss in two Pakistani families.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Neurohormones help control skin health and could treat skin disorders.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Stress can worsen skin conditions by affecting hormone levels and immune response.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Androgens and other hormones affect hair growth and skin conditions like acne.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Hormones control reproduction and are crucial for body balance.

Hair loss needs more research for better treatments.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Melatonin affects skin and hair color and protects skin cells, with potential benefits for hair growth and skin health.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Human alpha defensin 5 helps heal wounds, reduce bacteria, and grow hair on burned skin.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.